Gilead Sciences · Health Care
GILD
$134.28
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19.吉利德科学公司是一家美国生物制药公司，总部位于加利福尼亚州福斯特城，专注于研发用于治疗HIV/AIDS、乙型肝炎、丙型肝炎、流感和COVID-19的抗病毒药物。
Mixed profile混合特征
Large cap大盘
$167B
Engine stance引擎立场2026-07-20
Neutral — no clear edge中性 — 无明显优势
Daily low forming, but the bigger trend is still bearish. Small size only; stop below 123.76.日线低点正在形成，但大趋势仍偏空。只适合小仓位；止损设于 123.76 下方。
Price Chart价格图表
Key Statistics关键统计
Price价格
$134.28
12.8% below 52-week high低于52周高点 12.8%
Market Cap市值
$167B
Normal volume正常成交量
P/E Ratio市盈率
19.6x
28.9x sector median
Forward P/E预测市盈率
13.8x
EPS每股收益 $6.86
Beta贝塔
0.35
Moves about 0.3x the market波动幅度约为市场的 0.3 倍
Dividend Yield股息收益率
2.44%
RSI (14)RSI（14）
57
Neutral zone中性区域
Next Earnings下次财报
2026-08-06 (18d)
Volatility Rank波动率分位
92th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
2.0% of float
Performance价格表现
| Period周期 | GILD | S&P 500 | vs Index对比指数 |
|---|---|---|---|
| 1 Week近1周 | +3.4% | -1.5% | Beat the index by 4.9 points跑赢指数 4.9 个百分点 |
| 1 Month近1月 | +7.0% | +0.6% | Beat the index by 6.4 points跑赢指数 6.4 个百分点 |
| 3 Months近3月 | -1.8% | +4.7% | Lagged the index by 6.5 points落后指数 6.5 个百分点 |
| 6 Months近6月 | +8.8% | +7.8% | Beat the index by 1.0 points跑赢指数 1.0 个百分点 |
| Year to date年初至今 | +11.8% | +9.1% | Beat the index by 2.7 points跑赢指数 2.7 个百分点 |
| 1 Year近1年 | +26.6% | +19.4% | Beat the index by 7.2 points跑赢指数 7.2 个百分点 |
| 3 Years近3年 | +89.5% | +69.4% | Beat the index by 20.1 points跑赢指数 20.1 个百分点 |
| 5 Years近5年 | +134.8% | +83.9% | Beat the index by 50.9 points跑赢指数 50.9 个百分点 |
Technicals技术面
Active signals活跃信号
MA Sell (100)1-Day Return (cross-sectional rank → top/bottom gainers)Valuation cheapness percentile (0–1, higher = cheaper vs peers)Insider Power (0–100) — quality-weighted Form-4 open-market trades (role × size × recency); 50 = neutralInsider Sell signal — fires when Insider Power ≤ 40 (net selling on quality-weighted basis)
RSI (14)RSI（14）
57
Neutral zone中性区域
vs 50-day相对50日均线
+3.7% vs 50-day avg
vs 200-day相对200日均线
+3.6% vs 200-day avg
Trend strength (ADX)趋势强度（ADX）
18
No clear trend无明显趋势
Volatility rank波动率分位
92th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$131.25
Don't chase above不追高于
$134.30
Stop止损
$123.80
Bounce — turn not confirmed; wait反弹 — 转向未确认，先观望
Earnings财务业绩
18
days until next report天后公布财报
2026-08-06
Estimates being cut预期下调
Earnings call transcripts — coming soon财报电话会议记录 — 即将上线
Valuation估值
| Multiple指标 | GILD | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 19.58x | 28.92 | 74% |
| P/E (forward)市盈率（预测） | 13.8x | — | — |
| P/B市净率 | 7.34x | 3.52 | 18% |
| P/S市销率 | 5.66x | 3.02 | 27% |
| Earnings yield盈利收益率 | 5.11% | 2.72 | 81% |
| FCF yield自由现金流收益率 | 5.67% | 3.94 | 72% |
| Shareholder yield股东收益率 | 1.15% | 1.89 | 35% |
| EV/EBITDA企业价值/EBITDA | 17.71x | 18.21 | 52% |
| P/FCF市值/自由现金流 | 17.62x | 22.42 | 68% |
Analyst price targets — coming soon分析师目标价 — 即将上线
Financials财务数据
Revenue营业收入
5yr CAGR5年复合增速: 3.6%
Earnings Per Share每股收益
5yr CAGR5年复合增速: 132.4%
Free Cash Flow自由现金流
Margins利润率
37.5%Return on Equity股本回报率
14.4%Return on Assets资产回报率
Leverage杠杆
| Net debt / EBITDA净债务/EBITDA | 1.67 |
| Current ratio流动比率 | 1.55 |
Capital Allocation资本配置
| Buybacks (TTM)回购（TTM） | $1.9B |
| Stock-based comp股权薪酬 | $894.0M |
| Share count change (1y)股数变化（1年） | -0.4% |
Piotroski皮奥特罗斯基 7/9
Altman Z阿尔特曼Z: safe (4.3)
Clean稳健
Snapshot Gauges综合指标
Valuation vs Sector估值相对行业
Roughly fair vs sector相对行业估值合理
Cheaper than 49% of its sector on blended multiples综合估值倍数低于行业内 49% 的公司
Beta市场敏感度
0.35×
0.21×3×
Moves about 0.3× the market波动幅度约为市场的 0.3 倍
Financial Health财务健康
7/9
Altman阿尔特曼: safe
Strong financial health财务健康状况良好
Dividend分红
2.44%
Pays a dividend (2.44% yield)有分红（收益率 2.44%）
Why Is It Moving为何波动
News新闻
1 recent stories — mixed1 篇最新报道，多空参半
Sector / Theme行业/主题
Big Pharma theme — #3 of 46 themes「大型药企」主题 — 46 个主题中第 3 位
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
Death cross on GILDGILD 死叉
Options Positioning期权持仓
Market makers are net long gamma — price pinned near current level做市商净持有正伽玛，价格倾向于在当前水平附近震荡
Expected daily move预期日波动
±2.12%
Expected weekly move预期周波动
±4.75%
Call wall看涨密集区
$150
Put wall看跌密集区
$120
Gamma flip伽玛翻转
$108
25d risk reversal25d风险逆转
-0.9%
Skew: 偏斜：balanced
Ownership & Smart Money持仓与聪明钱
Insider activity内部人员活动: -$61.0M net (0 buyers, 6 sellers)-$61.0M 净值（0 买家，6 卖家）
Signal History信号历史
COUNTERTREND BOUNCE
UNCONFIRMED TURN
Jul 17, 2026
Death cross on GILDGILD 死叉
The 50-day average crossed below the 200-day — a slow, widely-watched bearish trend signal. $134.28.50日均线下穿200日均线 — 一个滞后但广受关注的看空趋势信号。$134.28。
Jul 15, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 13, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 10, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 9, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 7, 2026
UNCONFIRMED TURN → BOTTOMING未确认转向 → 筑底中
BUY SETUP买入预备
Jul 6, 2026
UNCONFIRMED TURN → BOTTOMING未确认转向 → 筑底中
BUY SETUP买入预备
Showing last 15 of显示最近15条，共 3080 signals条信号
Factor Profile因子特征
Composite factor score综合因子得分: -0.11
Value价值
-0.6
Quality质量
-0.4
Investment资本投入
+0.5
Shareholder payout股东回报
-0.7
Low volatility低波动
+0.8
Low market beta低市场敏感度
+0.7
Earnings quality盈利质量
-0.4
Short interest空头兴趣
+0.8
Company Profile公司档案
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19.吉利德科学公司是一家美国生物制药公司，总部位于加利福尼亚州福斯特城，专注于研发用于治疗HIV/AIDS、乙型肝炎、丙型肝炎、流感和COVID-19的抗病毒药物。
Recent News最新动态
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。